Infectious Diseases Clinical Research Unit (CRU)
The Infectious Diseases Clinical Research Unit conducts single and multi-centre investigator and industry-initiated studies.
The studies vary in type such as:
- Testing the efficacy and safety of new or novel drug treatments
- Observational studies that aim to collect data from populations, and typically involve large numbers of participants followed for many years
- Specifics of a group at a single point in time
The unit is based at The Alfred and enjoys close links with other primary and tertiary health care providers with similar interests, including:
- Melbourne Sexual Health Centre
- Royal Melbourne Hospital
- Monash Health and inner city practices
- Prahran Market, Centre and Northside Clinics
We also collaborate closely with the Burnet Institute, Monash University, The Doherty Institute, Baker Heart & Diabetes Institute, and the Kirby Institute (Sydney).
- International multi-site clinical trial for new treatments in Infectious Diseases including HIV, Hepatitis C, Influenza and Clostridium Difficile
- Clinical trials in collaboration with the Doherty Institute in the field of HIV Cure
- Leading or participating in multi-site surveillance and observational studies such as, FluCAN (The Influenza Complications Alert Network) and the Australian HIV Observational Database
- Other studies in General Infectious Diseases as a member of the Australian Society for Infectious Diseases Clinical Research Network
- Support for research implementation, monitoring and ethics applications for our collaborators
- Other related infectious diseases clinical research
If you are interested in participating in a clinical study, register your interest by contacting the Clinical Research Unit.
You can also be placed on a contact list for future studies.
All potential participants in a study are provided with a Patient Information and Consent Form and are encouraged to talk to either their physician or to a member of the Clinical Research Unit before agreeing to be involved in a study.
This study will look to see if the immune checkpoint markers CTLA-4 and PD-1 can be found on white blood cells from the blood and lymph nodes of HIV+ participants taking ART. The study is trying to find out if CTLA-4 and PD-1 can be found on cells with latent HIV.Find out more